JEANINE TACKLA: Open Payments
NPI 1255612537 · KELLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 11 payments from 9 companies in 2025. Trend: 2023 $20 · 2024 $97 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $138 |
| KYOWA KIRIN, INC. | 2 | $113 |
| UCB, Inc. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $14 |
Products named: Ozempic, Bimzelx, CRYSVITA, NURTEC ODT, Veozah, REXULTI, XIFAXAN, INSPIRE.
Industry payments across TX — which companies pay providers there.
